Morning Immunotherapy: The Key to Better Outcomes?

Administering immunotherapy in the morning may influence treatment outcomes due to circadian rhythms affecting immune and cancer cell replication. A personal case from 1995 suggests scheduling chemotherapy in the evening could reduce immune suppression, but lack of clinical studies and systemic barriers hinder research and protocol changes. The discussion emphasizes the potential of chronotherapy, the importance of evidence-based medicine, and the need for more flexible, innovative approaches in medical research, balanced with ethical considerations and rigorous testing.